Literature DB >> 9573400

Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart.

K K Chan1, S K Tsui, S M Lee, S C Luk, C C Liew, K P Fung, M M Waye, C Y Lee.   

Abstract

A full-length cDNA clone encoding a novel LIM-only protein was isolated and sequenced from a human fetal heart cDNA library. This full-length clone consists of 1416 base pairs and has a predicted open reading frame (ORF) encoding 279 amino acids. The ORF of this polypeptide codes for the human heart-specific four and a half LIM-only protein 2 (FHL2). It possesses an extra zinc finger that is a half LIM domain and four repeats of LIM domain. When the human FHL2 cDNA probe was used to hybridize with poly-A RNA of various human tissues, a very strong signal could be seen in heart tissues, and only moderately low signals could be detected in placenta, skeletal muscle and ovary. Virtually no signal could be detected in brain, lung, liver, kidney, pancreas, spleen, thymus, prostate, testis, small intestine, colon or peripheral blood leukocyte. FHL2 was mapped to chromosome 2q12-q13 by fluorescent in-situ hybridization (FISH).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573400     DOI: 10.1016/s0378-1119(97)00644-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  46 in total

1.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.

Authors:  Nicole H Purcell; Dina Darwis; Orlando F Bueno; Judith M Müller; Roland Schüle; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  FHL3 negatively regulates human high-affinity IgE receptor beta-chain gene expression by acting as a transcriptional co-repressor of MZF-1.

Authors:  Kyoko Takahashi; Chiyuki Matsumoto; Chisei Ra
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

4.  The expression pattern of FHL2 during mouse molar development.

Authors:  Jianxin Du; Qiang Wang; Li Wang; Xiaoying Wang; Pishan Yang
Journal:  J Mol Histol       Date:  2012-03-30       Impact factor: 2.611

5.  FHL2 mediates tooth development and human dental pulp cell differentiation into odontoblasts, partially by interacting with Runx2.

Authors:  Jianxin Du; Qiang Wang; Pishan Yang; Xiaoying Wang
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

6.  Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector.

Authors:  R Ramalingam; S Rafii; S Worgall; N R Hackett; R G Crystal
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2.

Authors:  Alison A Hill; Paul R Riley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1.

Authors:  Aurore Morlon; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

9.  The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.

Authors:  Franziska Dierck; Christian Kuhn; Claudia Rohr; Susanne Hille; Julia Braune; Samuel Sossalla; Sibylle Molt; Peter F M van der Ven; Dieter O Fürst; Norbert Frey
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

10.  Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.

Authors:  Thomas Günther; Cecilia Poli; Judith M Müller; Philip Catala-Lehnen; Thorsten Schinke; Na Yin; Sandra Vomstein; Michael Amling; Roland Schüle
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.